Results 61 to 70 of about 26,115 (197)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity [PDF]

open access: yes, 2017
Michael Huss,1 Praveen Duhan,2 Preetam Gandhi,3 Chien-Wei Chen,4 Carsten Spannhuth,3 Vinod Kumar5 1Child and Adolescent Psychiatry, University Medicine, Mainz, Germany; 2Global Medical Affairs, Novartis Healthcare Pvt.
Duhan P   +5 more
core  

Pharmacological profile of methylphenidate-based designer drugs [PDF]

open access: yes, 2018
Background: Methylphenidate-based designer drugs are new psychoactive substances (NPS) that are used outside medical settings and their pharmacology is largely unexplored.
Liechti, ME   +17 more
core   +1 more source

ADHD : from childhood into adulthood [PDF]

open access: yes, 2013
This is an overview of the some of the most recent and seminal research done on Attention Deficit Hyperactivity Disorders (ADHD). ADHD is currently one of the most common reasons for referral to child mental health services and still is under-recognised ...
Makhoul, Samer, Camilleri, Nigel
core  

Lens opacities in children using methylphenidate hydrochloride [PDF]

open access: yes, 2017
Purpose: To assess clinical findings of eye examination in children having attention deficit hyperactivity disorder (ADHD) administered with methylphenidate hydrochloride.
Duman, Rahmi   +7 more
core   +1 more source

Cardiovascular Risks of Methylphenidate in Children with ADHD

open access: yesJournal of Education, Health and Sport
Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder affecting millions of children worldwide. Methylphenidate is one of the most prescribed medications for managing ADHD symptoms due to its proven ...
Adrianna Czachor   +7 more
doaj   +1 more source

The Impact of Methylphenidate on Sexual Functions: A Systematic Review of Benefits and Risks

open access: yesPharmaceuticals
Background: Methylphenidate is a psychostimulant that enhances dopamine and norepinephrine neurotransmission through the mechanism of reuptake inhibition at the synaptic cleft.
Rafał Bieś   +4 more
doaj   +1 more source

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine [PDF]

open access: yes, 2016
Alain Joseph,1 Martin Cloutier,2 Annie Guérin,2 Roy Nitulescu,2 Vanja Sikirica3 1Global HEOR and Epidemiology, Shire, Zählerweg, Zug, Switzerland; 2Analysis Group, Inc., Montreal, Quebec, Canada; 3Global HEOR and Epidemiology, Shire, Wayne ...
Guérin A   +4 more
core  

ANOVA results (effects of methylphenidate). [PDF]

open access: yes, 2012
ANOVA results (effects of methylphenidate).
Andreas J. Fallgatter (158018)   +6 more
core   +1 more source

Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists [PDF]

open access: yes, 2017
Joshua Caballero,1 Edress H Darsey,2 Faith Walters,2 Heidi W Belden2 1Department of Clinical and Administrative Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, FL, 2Pfizer Inc, New York, NY, USA Abstract: Attention-deficit ...
Walters F   +3 more
core  

Actigraphic Recording of Manic Symptoms Induced by Methylphenidate

open access: yesCase Reports in Medicine, 2009
Objective. Attention-deficit hyperactivity disorder (ADHD) is a developmental disorder characterized by a long-standing pattern of impulsive behavior, hyperkinesia, and inattention.
Tuuli Lahti   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy